Venus Remedies – Express Pharma

Venus Remedies receives Saudi FDA approval for Plerixafor

Tariffs & sustainability: Why Indian pharma can no longer treat them as separate conversations

Venus Remedies receives Argentina approval for Ceftriaxone, expands Latin America presence

Industry calls Union Budget 2026 a defining moment for India’s biopharma future

Venus Remedies receives second PLI incentive disbursement, reinforcing manufacturing strength

Venus Remedies secures Marketing Authorization for Ceftazidime + Avibactam in Indonesia

Advanced excipients could emerge as India’s next big pharma advantage

Venus Remedies’ Methotrexate, Cefuroxime, and Irinotecan enters Vietnam

Venus Remedies launches Venus Global Fulfillment Center to enhance global supply chain

Driving innovation in India’s pharma R&D through cell and gene therapy